Lupin Pharmaceuticals recalls 28mg Memantine Hydrochloride Extended-release Capsules due to failed dissolution tests. Rx-only medication with specific NDC numbers and expiration dates.
“Lupin Memantine Capsules Recall: Failed Dissolution Specifications.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37659-lupin-memantine-capsules-recall-failed-dissolution-specifications. Based on FDA recall #D-0629-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0629-2020%22&limit=1).
Lupin Pharmaceuticals Inc. recalled Memantine Hydrochloride Extended-release Capsules, 28mg, due to failed dissolution specifications, the FDA said on Dec. 10, 2019. The voluntary Class III recall affects 3,726 bottles distributed nationwide.
Packaging: 90-count bottles (NDC 68180-249-09) and 500-count bottles (NDC 68180-249-02)
Lot codes: H901787, H901788
Expiration date: March 2021
The hazard
The recall was initiated because high out-of-specification results were observed at stability studies for the capsules. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Lupin Pharmaceuticals Inc. has had 90 other recalls on record since Jan. 31, 2013. Other recent recalls of similar products include Lupin Clobetasol Cream Recall (Aug. 3, 2026), Lupin Glucagon Emergency Kit Recall (June 23, 2026), and Lupin prednisolone acetate ophthalmic suspension recall (June 4, 2026). Other recent recalls of similar products include Harvard Drug Group Memantine Capsules Recall (March 24, 2026), Sun Pharmaceutical Lisdexamfetamine Capsules Recall (Oct. 28, 2025), and Supernus Trokendi XR 50mg Capsules: Failed Dissolution Specifications Recall (Aug. 31, 2026).
How to tell if you have this one
Check for 28mg Memantine Hydrochloride Extended-release Capsules in 90-count bottles (NDC 68180-249-09) or 500-count bottles (NDC 68180-249-02). These were manufactured for specific lots with expiration dates up to March 2021.
Brand
Lupin Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Medication Details
Verify the product's NDC number is 68180-249-09 or 68180-249-02 to confirm it's part of the recall.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0629-2020 (December 10, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0629-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.